trial

Mindfulness-Based Therapy for Serious Mental Illness

NCTId NCT06880796
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Enrolling By Invitation
Enrollment 160 (estimated)
Sponsored by Butler Hospital
Primary completion 2029-04-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Enrolling By Invitation
Enrollment
160 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2025-11-25
Primary completion
2029-04-01
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Mindfulness-based therapy

Sponsors

Butler HospitalLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
Brandon Gaudiano, PhDPrincipal Investigator

Sites

1 total
Providence, United States

Facts & assertions

4 sourced
Enrollment
160
Phase
NA
Primary Completion Date
2029-04-01
Status
ENROLLING_BY_INVITATION
relationships
The graph out of here
drug
Mindfulness-based therapy
drug
lead_sponsor
Butler Hospital
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Bipolar Disorder
indication
Major Depressive Disorder
indication
Serious Mental Illness
indication
investigator
Brandon Gaudiano, PhD
person